RECRUITING

Evaluating Process of Change in Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for Depression

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will compare two psychological treatments for major depressive disorder (MDD): cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT). Both treatments are well-studied and supported by evidence as effective options for people experiencing depression. These treatments will be delivered in an online group format via Zoom. The study will enroll up to 100 participants with depression. Half of the participants will receive online group CBT and half will receive online group ACT. There will be up to 10 members in each group. For both conditions, treatment will be provided over 8 weeks, with a 6-month follow-up period. Enrollment will be ongoing and groups will occur simultaneously. Potential participants are asked to complete an initial screening and an intake evaluation to determine eligibility. They will then receive 8-weeks of treatment. Participants will complete self-report questionnaires throughout their time in the study.

Official Title

Researching and Improving Psychotherapy Techniques in Interventions for DEpression (RIPTIDE)

Quick Facts

Study Start:2024-01-15
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06245096

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * diagnosis of major depressive disorder (MDD) according to DSM-V criteria (APA, 2013)
  2. * 18 years of age or older
  3. * access to a private location with a stable internet connection and a working video camera
  4. * lives in California
  5. * able to understand and speak English
  6. * able and willing to give informed consent
  1. * current diagnosis other than MDD if it constitutes the predominant aspect of the clinical presentation and if it requires treatment other than that being offered
  2. * clear indication of secondary gain (e.g., court ordered treatment)
  3. * current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis.

Contacts and Locations

Study Contact

Iony D Ezawa, PhD
CONTACT
(213) 262-9992
ezawa@usc.edu

Principal Investigator

Iony D Ezawa, PhD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

University of Southern California
Los Angeles, California, 90007
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • Iony D Ezawa, PhD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-15
Study Completion Date2026-01

Study Record Updates

Study Start Date2024-01-15
Study Completion Date2026-01

Terms related to this study

Additional Relevant MeSH Terms

  • Depression